文献速递神经核医学肿瘤 PET/CT

基于生成对抗网络的去噪用于18F FP-CIT PET/CT扫描时间缩短与运动校正:一项多中心外部验证研究

GAN-based Denoising for Scan Time Reduction and Motion Correction of 18 F FP-CIT PET/CT: A Multicenter External Validation Study.
PubMed 文献 · Clin Nucl Med · 2025-07-01

本研究利用391例疑似帕金森综合征患者的18F FP-CIT PET/CT数据,开发双对比学习生成对抗网络(DCLGAN)从短时扫描预测全时PET图像。结果显示5分钟去噪图像质量最优,视觉分析≥3分钟可接受,诊断指标稳定,外部验证中不同医院扫描仪达到相应质量基准,9例患者运动伪影校正后纹状体DSC从0.89提升至0.95。

要点

  • 5分钟去噪图像质量最优(NRMSE 0.008,PSNR 42.13,SSIM 0.98)。
  • 视觉分析≥3分钟去噪图像评为可接受或更高。
  • 诊断指标ISR在去噪后保持稳定,运动伪影校正使纹状体DSC从0.89提升至0.95。

核心结论

  • 深度学习模型能从短时扫描生成高质量18F FP-CIT PET图像,提升患者舒适度、减少运动伪影并保持诊断精确性。
  • 研究为利用图像质量评估指标确定不同灵敏度扫描仪的合适扫描时长提供了见解。

研究设计与样本

  • 多中心外部验证研究,使用391例疑似帕金森综合征患者的18F FP-CIT PET/CT数据,其中250例用于训练/验证,141例用于测试(医院A)。
  • 外部验证使用2家不同扫描仪医院的数据(医院B:1、3、5、10分钟;医院C:1、3、5分钟)。
  • 运动伪影校正评估使用9例患者的Dice相似系数(DSC)。

主要发现

  • 医院A中NRMSE、PSNR和SSIM随扫描时长改善,5分钟去噪图像质量最优(NRMSE 0.008,PSNR 42.13,SSIM 0.98)。
  • 视觉分析将≥3分钟扫描的去噪图像评为可接受或更高。
  • 各去噪图像的均值BP ND差异(95%CI)分别为0.19(-0.01,0.40)、0.11(-0.02,0.24)、0.08(-0.03,0.18)和0.01(-0.06,0.07),置信区间显著缩小。
  • 区分NPD、IPD和APD效应量最高的ISR(PP/AP、PP/VS、PC/VP)在去噪后保持稳定。
  • 外部验证显示医院B的10分钟去噪图像和医院C的1分钟去噪图像达到医院A图像质量指标的基准,视觉分析和BP ND置信区间趋势相似。

关键数值与推荐

  • 医院A去噪图像质量指标:5分钟去噪图像NRMSE 0.008,PSNR 42.13,SSIM 0.98。
  • 各去噪图像均值BP ND差异(95%CI):0.19(-0.01,0.40)、0.11(-0.02,0.24)、0.08(-0.03,0.18)、0.01(-0.06,0.07)。
  • 运动伪影校正后纹状体DSC从0.89提升至0.95。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: AI-driven scan time reduction is rapidly transforming medical imaging with benefits such as improved patient comfort and enhanced efficiency. A Dual Contrastive Learning Generative Adversarial Network (DCLGAN) was developed to predict full-time PET scans from shorter, noisier scans, improving challenges in imaging patients with movement disorders. PATIENTS AND METHODS: 18 F FP-CIT PET/CT data from 391 patients with suspected Parkinsonism were used [250 training/validation, 141 testing (hospital A)]. Ground truth (GT) images were reconstructed from 15-minute scans, while denoised images (DIs) were generated from 1-, 3-, 5-, and 10-minute scans. Image quality was assessed using normalized root mean square error (NRMSE), peak signal-to-noise ratio (PSNR), structural similarity index measure (SSIM), visual analysis, and clinical metrics like BP ND and ISR for diagnosis of non-neurodegenerative Parkinson disease (NPD), idiopathic PD (IPD), and atypical PD (APD). External validation used data from 2 hospitals with different scanners (hospital B: 1-, 3-, 5-, and 10-min; hospital C: 1-, 3-, and 5-min). In addition, motion artifact reduction was evaluated using the Dice similarity coefficient (DSC). RESULTS: In hospital A, NRMSE, PSNR, and SSIM values improved with scan duration, with the 5-minute DIs achieving optimal quality (NRMSE 0.008, PSNR 42.13, SSIM 0.98). Visual analysis rated DIs from scans ≥3 minutes as adequate or higher. The mean BP ND differences (95% CI) for each DIs were 0.19 (-0.01, 0.40), 0.11 (-0.02, 0.24), 0.08 (-0.03, 0.18), and 0.01 (-0.06, 0.07), with the CIs significantly decreasing. ISRs with the highest effect sizes for differentiating NPD, IPD, and APD (PP/AP, PP/VS, PC/VP) remained stable post-denoising. External validation showed 10-minute DIs (hospital B) and 1-minute DIs (hospital C) reached benchmarks of hospital A's image quality metrics, with similar trends in visual analysis and BP ND CIs. Furthermore, motion artifact correction in 9 patients yielded DSC improvements from 0.89 to 0.95 in striatal regions. CONCLUSIONS: The DL-model is capable of generating high-quality 18 F FP-CIT PET images from shorter scans to enhance patient comfort, minimize motion artifacts, and maintain diagnostic precision. Furthermore, our study plays an important role in providing insights into how imaging quality assessment metrics can be used to determine the appropriate scan duration for different scanners with varying sensitivities.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Han H, Choo K, Jeon TJ, et al. GAN-based Denoising for Scan Time Reduction and Motion Correction of 18 F FP-CIT PET/CT: A Multicenter External Validation Study. Clin Nucl Med. 2025. PMID: 40590063. doi:10.1097/RLU.0000000000006040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。